secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K/A
Filed at:   2023-05-24T23:59:59+00:00
Accession:  0001104659-23-064154
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

PowerUp Acquisition amends 8-K to correct redemption price to $284M ($10.55/share)
--------------------------------------------------------------------------------

- Corrects redemption price from $283M ($10.51/share) to $284M ($10.55/share) for public shares tendered at May 2023 EGM.
- 26,946,271 public shares redeemed; approx $284M removed from trust account, leaving $19M and 1,803,729 shares outstanding.
- No other changes to original filing; this is solely a price correction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000110465923064154/0001104659-23-064154-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000110465923064154/tm2316911d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-064154

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer